Grants
2021/4 – 2024/3: Project title: Selective Early Medical Treatment of the Patent Ductus Arteriosus in Extremely Low Gestational Age Infants: A Pilot Randomized Controlled Trial (the SMART PDA Trial). Funding Source: Canadian Institutes of Health Research (CIHR) Early Career Investigators in Maternal, Reproductive, Child and Youth Health Grant 2020 (Principal Investigator). Total Funding – $208,998 (Canadian dollar) [including 1:1 matching fund support from the Dalhousie Medical Research Foundation; IWK Health Research; Department of Pediatrics, Dalhousie University]
2020/1 – 2024/1: Project title: Relative effectiveness and safety of pharmacotherapeutic agents for treatment patent ductus arteriosus (PDA) in preterm infants: A National Comparative Effectiveness Research (CER) Project. Funding Source: Canadian Institutes of Health Research (CIHR) Project Grant Fall 2019 (Principal Investigator). Total Funding – $313,652 (Canadian dollar)
2022/9 – 2025/8. Project title: Increasing capacity for Maternal and PAediatric Clinical Trials (IMPACT) in Canada. Principal Applicant: Dr. Lauren Kelly, Associate Professor, Depts. of Pharmacology and Therapeutics, and Community Health Sciences, University of Manitoba. Funding Source: CIHR Training Grant: Clinical Trials Training Platforms (Co-Investigator). Total Funding – $ 4,907,350 (Canadian dollar)
2022/9 – 2025/8. Project title: Increasing capacity for Maternal and PAediatric Clinical Trials (IMPACT) in Canada. Principal Applicant: Dr. Jean Bourbeau, Research Institute at McGill University Health Centre. Funding Source: CIHR Training Grant: Clinical Trials Training Platforms (Co-Investigator). Total Funding – $ 11.3M (Canadian dollar)
2022/4 – 2027/3. Project title: Dopamine vs. Norepinephrine for hypotension in very preterm infants with late-onset sepsis: A National Comparative Effectiveness Research (CER) Project. Principal Applicant: Dr. Amish Jain, Associate Professor, University of Toronto. Funding Source: Canadian Institutes of Health Research (CIHR) Project Grant Fall 2021 (Co-Investigator). Total Funding – $ 473,761 (Canadian dollar)
2021/6 – 2022/5. Project title: Parental presence restrictions due to COVID-19: Examining impact and priorities for neonatal care (The PRESENCE Study). Principal Applicant: Dr. Marsha Campbell-Yeo, Professor, Dalhousie University. Funding Source: Canadian Institutes of Health Research (CIHR) Emerging COVID-19 Research Gaps and Priorities Funding Opportunity (Co-Investigator). Total Funding – $193,100 (Canadian dollar)
2021/1 – 2025/1: Project title: REdefining the SignificancE and Treatment threshold for Patent Ductus Arteriosus in preterm infants (RESET-PDA). Principal Applicant: Dr. Dany Weisz, Assistant Professor, University of Toronto. Funding Source: Canadian Institutes of Health Research (CIHR) Project Grant Fall 2020 (Co-Investigator). Total Funding – $566,100 (Canadian dollar)
Honours &
Awards
2022/11 – Recipient of the Emerging Professional Award at the 2022 Discovery Awards for Science and Innovation: Discovery Centre, Nova Scotia
2022/5 – Invited panelist on "Game Changers in Health Research and Health Innovation" event: Parliamentary Health Research Caucus, Research Canada
2020/12 – Department of Pediatrics Research Award for Research Excellence [Category: In the first 10 years of an academic appointment], Department of Pediatrics, Dalhousie University
2020/12 – 2021 CNPRM (Canadian National Perinatal Research Meeting) Early Career Researcher Invited Lectureship
2019/6 – Rising Star Award: Canadian Child Health Clinician Scientist Program (CCHCSP), Toronto, ON
2019/5 – Richard Merritt Special Appreciation Award: Canadian Society of Hospital Pharmacists, Ottawa, ON